Effect of Lap-Band Induced Weight Loss on Serum PSA Levels, Testosterone, Estrogen and Other Serum Markers
The main objective of this study is to determine whether interpretation of PSA levels in
morbidly obese men require correction due to the obesity itself. Secondary outcome measures
that will be followed include the affect of obesity and weight loss on testosterone,
estradiol and leptin. In as much as these might also affect PSA, we will be measuring these
values as well. Also, we do not know the effects of lap-band induced weight loss on
clinical outcome measures of sexual, bowel and urinary function. Thus we will aim to
investigate these parameters as well.
Observational
Observational Model: Case-Only, Time Perspective: Prospective
PSA value
18 months
Jason Wynberg, MD
Principal Investigator
MMC
United States: Institutional Review Board
07/09/VA18
NCT00562341
November 2007
December 2009
Name | Location |
---|---|
Maimonides Medical Center | Brooklyn, New York 11219 |